Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib.
Oncol Lett
; 20(2): 1376-1382, 2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-32724380
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncol Lett
Year:
2020
Type:
Article
Affiliation country:
Czech Republic